#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Advanced systemic mastocytosis Primary hyperoxaluria Mantle cell lymphoma stage III C3 glomerulopathy Cytokine release syndrome Fungal infection Niemann-Pick disease Alveolar rhabdomyosarcoma Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Gastroenteropancreatic neuroendocrine tumour disease Crohn's disease Cognitive disorder Hereditary angioedema Chronic lymphocytic leukaemia refractory Acute graft versus host disease in intestine More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Basic Information Synovial sarcoma recurrent Rhabdoid tumour – Diagnostics Familial haemophagocytic lymphohistiocytosis Glomerulonephritis membranoproliferative – Diagnostics Soft tissue sarcoma – Trials in Disease Factor VIII deficiency – Trials in Disease Optic glioma – Basic Information Pemphigus – Diagnostics Glycogen storage disease type I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rilpivirine Rosnilimab Fluoroethyltyrosine F-18 AMLENETUG Bromocriptine Oditrasertib Benzylpenicillin Doconexent Vsf1.01 Flecainide Sertindole Human Serum Albumin Ruxolitinib Corline Heparin Conjugate LY4170156 Nefopam Gadoteric Acid MZE829 Enzalutamide Linagliptin More therapies…

    Learn about Your Condition

    Alcohol abuse Hepatocellular carcinoma Cholestatic pruritus Appendicitis Squamous cell carcinoma Macular oedema Acne Diffuse large B-cell lymphoma Oedema peripheral Hyponatraemia Skin ulcer Pancreatic carcinoma recurrent Colour blindness Palmoplantar pustulosis KBG syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Medical Center Zdrave Lom EOOD

Medical Center Zdrave Lom EOOD

Ulitsa Panayot Volov 6, Lom, 3600, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity

    Recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Belgium Bulgaria Denmark Greece The Netherlands Sweden

  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Metformin
    • Cagrilintide
    • Dapagliflozin
    Bulgaria Croatia Czechia Denmark Finland Germany +9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!